Pretreatment with the NLRP3 inhibitor MCC950 had no effect on bacterial burden in mock (saline) or isotype control-treated mice, consistent with previous studies showing no role for NLRP3 in TB immunity in naïve animals6. Here, NLRP3 is linked to tuberculosis.